Burzynski Research Institute, Inc.
|
-0.01 USD
|
-1566.667%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
92.511%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
101.643%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
-1168.657%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
-429.595%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
102.857%
|
Qrons Inc.
|
-0.06 USD
|
-191.595%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Neon Bloom, Inc.
|
-0.00 USD
|
-11233.333%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
-195.652%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
-1600.0%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
96.834%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
99.665%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
-230.097%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
93.841%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
-94.508%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
-617.3%
|
Mesoblast Limited
|
-0.09 USD
|
-90.797%
|
Marizyme, Inc.
|
-1.44 USD
|
88.194%
|
Genus plc
|
0.12 USD
|
241.667%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
92.704%
|
Pharming Group N.V.
|
-0.02 USD
|
-955.901%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
-24185.714%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
59.524%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
-76.166%
|
ContraFect Corporation
|
-124.97 USD
|
99.864%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
-304.762%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
-1316.667%
|
IMV Inc.
|
-4.37 USD
|
96.11%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
-380.226%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
-169900.0%
|
ONE Bio Corp.
|
1.43 USD
|
111.888%
|
Accustem Sciences Inc.
|
-0.34 USD
|
50.0%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
70.69%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
-41.667%
|
Q BioMed Inc.
|
-0.08 USD
|
-117.67%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
-141.821%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
48.485%
|
Biomind Labs Inc.
|
-0.02 USD
|
-949.383%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
99.978%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
-2197.297%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
-754.271%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
-6983.333%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
-21150.0%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
34.615%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
-1831.818%
|
GB Sciences, Inc.
|
-0.00 USD
|
-4046.341%
|
Alpha Cognition Inc.
|
-0.15 USD
|
-13.333%
|
HST Global, Inc.
|
-0.03 USD
|
-509.319%
|
CSL Limited
|
2.73 USD
|
106.227%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
-239.321%
|
Halberd Corporation
|
-0.00 USD
|
-169900.0%
|
Enzolytics Inc.
|
-0.00 USD
|
-24185.714%
|
Agentix Corp.
|
-0.04 USD
|
-385.714%
|
Resverlogix Corp.
|
-0.01 USD
|
-1097.183%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
-125.464%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-5.16 USD
|
96.705%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
13176.923%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
777.291%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
-376.19%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
-750.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
-215.399%
|
Zenith Capital Corp.
|
-0.07 USD
|
-143.205%
|
Genscript Biotech Corporation
|
-0.05 USD
|
-274.449%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
-2598.413%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
95.491%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
-33900.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
-86.199%
|
Kadimastem Ltd
|
-0.78 USD
|
78.205%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
96.383%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
99.533%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
72.581%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
-1328.571%
|
LadRx Corporation
|
0.68 USD
|
125.0%
|
Regen BioPharma, Inc.
|
0.29 USD
|
158.621%
|
Regen BioPharma, Inc.
|
0.26 USD
|
165.385%
|
NovAccess Global Inc.
|
-0.23 USD
|
26.087%
|
Affymax, Inc.
|
-0.39 USD
|
56.41%
|
Itoco Inc.
|
-0.01 USD
|
-2136.842%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
-1600.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
-6700.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
-2935.714%
|
CytoDyn Inc.
|
-0.05 USD
|
-221.361%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
-33900.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
-665.766%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
99.889%
|
SYBLEU INC
|
-0.02 USD
|
-871.429%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
-1097.183%
|
International Stem Cell Corporation
|
-0.02 USD
|
-936.585%
|
Bioxytran, Inc.
|
-0.03 USD
|
-432.915%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
- USD
|
Infinity%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
-169900.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
97.872%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
85.593%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-0.03 USD
|
-400.0%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
-2598.413%
|
Neutra Corp.
|
-0.00 USD
|
-169900.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
99.82%
|
PureTech Health plc
|
-2.38 USD
|
92.857%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
79.518%
|
IXICO plc
|
-0.02 USD
|
-596.721%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
-199.296%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
87.407%
|
CSL Limited
|
5.47 USD
|
103.108%
|
Cellectis S.A.
|
-1.77 USD
|
90.395%
|